Projects

ROCK2 dependant radiation induced DNA repair in cervical carcinoma - A translational opportunity

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2017 - 2022

Project Lead

Sweta Srivastava

Authors

Annapurna Pranatharthi, Pavana Thomas, Avinash H Udayashankar, Chandra Bhavani, Srinag Bangalore Suresh, Sudhir Krishna, Jayashree Thatte, Nirmala Srikantia, Cecil R Ross, Sweta Srivastava

Project Status

completed

Project Type

Prospective (Funded DBT Biocare)